Table 2

Effect of in vivo depletion of each immune subpopulation on the long-lasting rejection of the second tumor challenge

GroupMice that rejected second tumor challenge, no. (%)*
WT/WGM-PBS 1/10 (10.0) 
KO/WGM-PBS 9/11 (81.8) 
KO/WGM-CD4 1/10 (10.0) 
KO/WGM-CD8 3/11 (27.3) 
KO/WGM-NK 2/10 (20.0) 
GroupMice that rejected second tumor challenge, no. (%)*
WT/WGM-PBS 1/10 (10.0) 
KO/WGM-PBS 9/11 (81.8) 
KO/WGM-CD4 1/10 (10.0) 
KO/WGM-CD8 3/11 (27.3) 
KO/WGM-NK 2/10 (20.0) 

Shown are combined pooled data from 2 independent experiments with similar results.

*

Assessed at day 15 after the second tumor challenge with WEHI3B cells.

χ2 test (P < .05).

Close Modal

or Create an Account

Close Modal
Close Modal